Interpace Biosciences, Inc. (IDXG)
1.523
-0.09
(-5.42%)
USD |
OTCM |
Aug 21, 16:00
Interpace Biosciences Market Cap : 42.18M for Aug. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 42.18M |
| August 20, 2026 | 44.60M |
| August 19, 2026 | 43.49M |
| August 18, 2026 | 44.32M |
| August 17, 2026 | 47.09M |
| August 14, 2026 | 45.98M |
| August 13, 2026 | 46.26M |
| August 12, 2026 | 46.26M |
| August 11, 2026 | 46.23M |
| August 10, 2026 | 47.09M |
| August 07, 2026 | 44.60M |
| August 06, 2026 | 45.43M |
| August 05, 2026 | 41.48M |
| August 04, 2026 | 45.15M |
| August 03, 2026 | 44.04M |
| July 31, 2026 | 42.02M |
| July 30, 2026 | 39.89M |
| July 29, 2026 | 42.98M |
| July 28, 2026 | 43.01M |
| July 27, 2026 | 42.79M |
| July 24, 2026 | 40.44M |
| July 23, 2026 | 40.17M |
| July 22, 2026 | 41.83M |
| July 21, 2026 | 41.67M |
| July 20, 2026 | 41.27M |
| Date | Value |
|---|---|
| July 17, 2026 | 42.24M |
| July 16, 2026 | 42.94M |
| July 15, 2026 | 44.88M |
| July 14, 2026 | 44.88M |
| July 13, 2026 | 41.55M |
| July 10, 2026 | 45.43M |
| July 09, 2026 | 45.38M |
| July 08, 2026 | 45.01M |
| July 07, 2026 | 45.57M |
| July 06, 2026 | 45.71M |
| July 02, 2026 | 45.15M |
| July 01, 2026 | 44.60M |
| June 30, 2026 | 45.15M |
| June 29, 2026 | 46.54M |
| June 26, 2026 | 45.71M |
| June 25, 2026 | 45.43M |
| June 24, 2026 | 47.09M |
| June 23, 2026 | 46.54M |
| June 22, 2026 | 45.15M |
| June 18, 2026 | 46.18M |
| June 17, 2026 | 45.57M |
| June 16, 2026 | 43.49M |
| June 15, 2026 | 43.63M |
| June 12, 2026 | 44.32M |
| June 11, 2026 | 45.71M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Exlites Holdings International, Inc. | 15.42M |
| Xcelerate, Inc. | 4.418M |
| Vivos Therapeutics, Inc. | 4.018M |
| Hinge Health, Inc. | 7.222B |
| PD-Rx Pharmaceuticals, Inc. | 5.510M |
Market Cap Related Metrics
| PE Ratio | 1.726 |
| PS Ratio | 1.167 |
| PEG Ratio | 0.0397 |
| Price to Book Value | 1.815 |
| Price to Free Cash Flow | 10.28 |
| Price | 1.523 |
| Earnings Yield | 57.95% |
| PEGY Ratio | 0.0397 |
| Operating PE Ratio | 10.13 |
| Normalized PE Ratio | 1.732 |